Idiopathic HFrEF. Is there room left for defibrillators?

29 August 2020 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Francisco Fernandes Gama

Hospital de Santa Cruz, Carnaxide (Portugal)

34 More presentations in this session

Presentation thumbnail

Usefulness of late gadolinium enhancement cardiac magnetic resonance to predict appropriate therapies in implantable cardioverter defibrillator patients in primary prevention

Miss P. Sanchez Somonte (Girona, ES)

Abstract Slides

Presentation thumbnail

Incidence of sudden cardiac death after heart transplantation

Doctor G. Bonnet (Bordeaux, FR)

Abstract Slides

Presentation thumbnail

Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement

Doctor D. Akdis (Zurich, CH)

Abstract Slides

Presentation thumbnail

Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy

Doctor N. Parashar (Delhi, IN)

Abstract Slides

Presentation thumbnail

Arrhythmogenic cardiomyopathy is characterized by apex-to-base heterogeneity of right ventricular myocardial contractility and stiffness: an imaging-based patient-specific modeling study

Mr N. van Osta (Maastricht, NL)

Abstract Slides

Access the full session

Session thumbnail

Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters

The Event

ESC Congress 2020

29 August - 1 September 2020

You may be interested in

Congress Session

Risk assessment and prevention of sudden cardiac death in cardiomyopathies

Congress Presentation

Is left ventricular ejection fraction an effective predictor of ventricular arrhythmias in patients with dilated cardiomyopathy?

Congress Presentation

When to consider device therapy in HFrEF - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources